ssDNA	Single-stranded DNA
3D	Three-dimensional
HER2	Human epidermal growth factor receptor 2
SELEX	Systematic evolution of ligands by exponential enrichment
FDA	Food and Drug Administration
mAbs	Monoclonal antibodies
NSCLC	Non-small cell lung cancer
CRC	Colorectal cancer
VEGF	Vascular endothelial growth factor
AMD	Age-related macular degeneration
ER	Estrogen receptor
PR	Progesterone receptor
ERα	Estrogen Receptor α
IHC	Immunehistochemistry
CISH	Chromogenic in situ hybridization
FISH	Fluorescent in situ hybridization
Dox	Doxorubicin
PLGA	Paclitaxel (PTX) loaded poly (lactic-co-glycolic-acid)
TNBC	Triple negative breast cancer
PDT	Photo dynamic therapy
PET	Positron emission tomography
SPECT	Single photon emission computed tomography
MRI	Magnetic resonance imaging
NIR	Near-infrared irradition
CT	Computed tomography
USG	Ultrasonography
ATM	Ataxia Telangiectasia Mutated
BRCA-1	Breast Cancer susceptibility gene 1
BRCA-2	Breast Cancer susceptibility gene 2
RBD	Receptor-binding domain
LNA	Locked nucleic acid
GCE	Glassy carbon electrode
ECD	Extra-cellular domain
FACS-SELEX	Fluorescence-activated cell sorting SELEX
MSD-SELEX	Monoclonal surface display SELEX
TECS-SELEX	Target expressed on cell surface-SELEX
MLH1	MutL homolog 1
Bcl-2	B-cell lymphoma 2
siRNA	Small interfering RNA
PARP	Poly-ADP-ribose polymerase
TKIs	Tyrosine kinase inhibitors
HIV	Human Immunodeficiency Viruses
AptaBiD	Aptamer-facilitated biomarker discovery
PIK3CA	Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
TFPI	Tissue factor pathway inhibitor
NPs	Nanoparticles
PEG	Polyethyleneglycol
PTX	Paclitaxel
MUC1	Cell surface associated
PCR	Polymerase chain reaction
TNBC	Triple-negative breast cancer
3WJ	Three-way junction
CTLA4	Cytotoxic T lymphocyte antigen 4 CTLA4
nm	Nanometers
EGFR	Epidermal growth factor receptor